Rsv 2025 Adults Adopting. Merck said tuesday the agency had set a decision deadline of june 10, 2025, which would allow the company to launch the antibody medicine ahead of the typical rsv fall. One year after becoming available for older americans and pregnant women, receptive public opinion of respiratory syncytial virus (rsv) vaccines is.

Information about respiratory syncytial virus (rsv) disease, vaccines and recommendations for vaccination from the australian immunisation handbook. Rsvpref vaccine is safe, effective among adults aged 18 to 59 who are at high risk for severe rsv, study suggests january 06, 2025.